Trisodium phosphonoformate, a new antiviral compound

Area of Science:

• Virology
• Molecular Biology
• Pharmacology

Background:

• Herpesviruses are significant human and animal pathogens.
• Viral DNA polymerase is a key target for antiviral therapies.
• Developing selective inhibitors of viral DNA polymerase is crucial for effective treatment.

Purpose of the Study:

• To investigate the antiviral potential of trisodium phosphonoformate.
• To determine the inhibitory effect of trisodium phosphonoformate on herpesvirus-induced DNA polymerase activity.
• To evaluate the therapeutic efficacy of trisodium phosphonoformate against herpesvirus infections.

Main Methods:

• Assessing the selective inhibition of cell-free DNA polymerase activity induced by herpesvirus.
• Evaluating the antiviral effect in cell culture against herpes simplex virus types 1 and 2, pseudorabies virus, and infectious bovine rhinotracheitis virus.
• Testing therapeutic activity against cutaneous herpes simplex virus infection in guinea pigs.

Main Results:

• Trisodium phosphonoformate selectively inhibited cell-free DNA polymerase activity induced by herpesvirus.
• The compound exhibited antiviral effects on herpes simplex virus types 1 and 2, pseudorabies virus, and infectious bovine rhinotracheitis virus in cell culture.
• Trisodium phosphonoformate demonstrated good therapeutic activity against cutaneous herpes simplex virus infection in guinea pigs.

Conclusions:

• Trisodium phosphonoformate is a potent inhibitor of herpesvirus DNA polymerase.
• The compound possesses broad-spectrum antiviral activity against relevant herpesviruses in vitro.
• Trisodium phosphonoformate shows promise as a therapeutic agent for herpesvirus infections.